Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11248646rdf:typepubmed:Citationlld:pubmed
pubmed-article:11248646lifeskim:mentionsumls-concept:C0013216lld:lifeskim
pubmed-article:11248646lifeskim:mentionsumls-concept:C0229096lld:lifeskim
pubmed-article:11248646lifeskim:mentionsumls-concept:C0349644lld:lifeskim
pubmed-article:11248646lifeskim:mentionsumls-concept:C0238767lld:lifeskim
pubmed-article:11248646lifeskim:mentionsumls-concept:C0029189lld:lifeskim
pubmed-article:11248646lifeskim:mentionsumls-concept:C0851346lld:lifeskim
pubmed-article:11248646lifeskim:mentionsumls-concept:C0677874lld:lifeskim
pubmed-article:11248646lifeskim:mentionsumls-concept:C0439231lld:lifeskim
pubmed-article:11248646lifeskim:mentionsumls-concept:C0332293lld:lifeskim
pubmed-article:11248646pubmed:issue3lld:pubmed
pubmed-article:11248646pubmed:dateCreated2001-3-15lld:pubmed
pubmed-article:11248646pubmed:abstractTextWe report the first detailed case of testicular lymphoma managed with chemotherapy and radiation without orchiectomy. A 60-year-old man with Stage II extralymphatic bilateral testicular lymphoma refused orchiectomy, but underwent cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy and radiation. He remained disease free for 52 months, when a solitary central nervous system relapse to the vitreous humor was diagnosed. The optimal therapy for testicular lymphoma is unclear but often includes orchiectomy with adjuvant chemotherapy and radiation. Stage I testicular lymphoma can be cured by surgery alone; however, the relapse rates for all stages of testicular lymphoma are high despite systemic therapy. For Stage II disease and higher, chemotherapy/radiation is recommended; orchiectomy may not be mandatory.lld:pubmed
pubmed-article:11248646pubmed:languageenglld:pubmed
pubmed-article:11248646pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11248646pubmed:citationSubsetIMlld:pubmed
pubmed-article:11248646pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11248646pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11248646pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11248646pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11248646pubmed:statusMEDLINElld:pubmed
pubmed-article:11248646pubmed:monthMarlld:pubmed
pubmed-article:11248646pubmed:issn1527-9995lld:pubmed
pubmed-article:11248646pubmed:authorpubmed-author:DavisJ WJWlld:pubmed
pubmed-article:11248646pubmed:authorpubmed-author:SchellhammerP...lld:pubmed
pubmed-article:11248646pubmed:authorpubmed-author:SchlossbergS...lld:pubmed
pubmed-article:11248646pubmed:authorpubmed-author:MoriartyR PRPlld:pubmed
pubmed-article:11248646pubmed:issnTypeElectroniclld:pubmed
pubmed-article:11248646pubmed:volume57lld:pubmed
pubmed-article:11248646pubmed:ownerNLMlld:pubmed
pubmed-article:11248646pubmed:authorsCompleteYlld:pubmed
pubmed-article:11248646pubmed:pagination555lld:pubmed
pubmed-article:11248646pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:11248646pubmed:meshHeadingpubmed-meshheading:11248646...lld:pubmed
pubmed-article:11248646pubmed:meshHeadingpubmed-meshheading:11248646...lld:pubmed
pubmed-article:11248646pubmed:meshHeadingpubmed-meshheading:11248646...lld:pubmed
pubmed-article:11248646pubmed:meshHeadingpubmed-meshheading:11248646...lld:pubmed
pubmed-article:11248646pubmed:meshHeadingpubmed-meshheading:11248646...lld:pubmed
pubmed-article:11248646pubmed:meshHeadingpubmed-meshheading:11248646...lld:pubmed
pubmed-article:11248646pubmed:meshHeadingpubmed-meshheading:11248646...lld:pubmed
pubmed-article:11248646pubmed:meshHeadingpubmed-meshheading:11248646...lld:pubmed
pubmed-article:11248646pubmed:meshHeadingpubmed-meshheading:11248646...lld:pubmed
pubmed-article:11248646pubmed:meshHeadingpubmed-meshheading:11248646...lld:pubmed
pubmed-article:11248646pubmed:meshHeadingpubmed-meshheading:11248646...lld:pubmed
pubmed-article:11248646pubmed:meshHeadingpubmed-meshheading:11248646...lld:pubmed
pubmed-article:11248646pubmed:meshHeadingpubmed-meshheading:11248646...lld:pubmed
pubmed-article:11248646pubmed:meshHeadingpubmed-meshheading:11248646...lld:pubmed
pubmed-article:11248646pubmed:meshHeadingpubmed-meshheading:11248646...lld:pubmed
pubmed-article:11248646pubmed:meshHeadingpubmed-meshheading:11248646...lld:pubmed
pubmed-article:11248646pubmed:meshHeadingpubmed-meshheading:11248646...lld:pubmed
pubmed-article:11248646pubmed:meshHeadingpubmed-meshheading:11248646...lld:pubmed
pubmed-article:11248646pubmed:meshHeadingpubmed-meshheading:11248646...lld:pubmed
pubmed-article:11248646pubmed:year2001lld:pubmed
pubmed-article:11248646pubmed:articleTitleBilateral testicular lymphoma treated with chemotherapy and radiation without orchiectomy: complete response relapsed at 52 months in the vitreous humor.lld:pubmed
pubmed-article:11248646pubmed:affiliationDepartment of Urology, Eastern Virginia Medical School, Norfolk, Virginia, USAlld:pubmed
pubmed-article:11248646pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11248646pubmed:publicationTypeCase Reportslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11248646lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11248646lld:pubmed